OvaScience CEO Michelle Dipp, M.D., Ph.D., Joins Biotechnology Industry Organization’s Board Of Directors
Published: Dec 09, 2013
OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today the appointment of Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, to the Biotechnology Industry Organization’s (BIO) Emerging Companies Governing Board. BIO is the world's largest biotechnology industry trade organization.
Help employers find you! Check out all the jobs and post your resume.